Subcutaneous immunoglobulin use in immunoglobulin-naïve patients with primary immunodeficiency: a systematic review. Supplementary tables.

Supplementary Table 1. Search strategies

A. Embase search strategy performed March 29, 2021. Limits: February 1, 2019 – March 29, 2021

B. MEDLINE search strategy performed March 29, 2021. Limits: February 1, 2019 – March 29, 2021

C. Cochrane Library search strategy performed March 29, 2021. Limits: February 1, 2019 – March 29, 2021

D. BIOSIS search strategy (ProQuest Dialog Platform) performed March 30, 2021. Limits: February 1, 2019 – March 30, 2021

E. Search Results, by Database: Supplementary Searches; Search performed on March 29, 2021. Limits: February 2, 2019 to present

F. Results of registry searches; March 29, 2021

Supplementary Table 2. COMPLETED PRISMA CHECKLIST

Supplementary Table 3. Details of SCIG-dosing regimens or patient health and treatment pathways in IG-naïve patients

Supplementary Table 4. Information on Loading Regimens From the Available Studies

Supplementary Table 5. Summary of Quality of Included Studies